Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden

INTRODUCTION: Percutaneous hepatic perfusion with melphalan (PHP-M) for hepatic metastasis of uveal melanoma (LMUM) achieves high local response rates, but the individual clinical benefit is poorly defined. We aimed to determine cofactors of response and clinical outcomes including the probability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brüning, R., Tiede, M., Schneider, M., Wohlmuth, P., Weilert, H., Oldhafer, K., Stang, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484678/
https://www.ncbi.nlm.nih.gov/pubmed/32934846
http://dx.doi.org/10.1155/2020/5672048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484678/
https://www.ncbi.nlm.nih.gov/pubmed/32934846
http://dx.doi.org/10.1155/2020/5672048

Ejemplares similares